FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 76 filers reported holding FORTE BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84 | -60.6% | 126,900 | -38.0% | 0.00% | – |
| Q2 2023 | $213 | -1.4% | 204,800 | -4.1% | 0.00% | – |
| Q1 2023 | $216 | -22.3% | 213,500 | -23.1% | 0.00% | – |
| Q4 2022 | $278 | -99.9% | 277,500 | -37.5% | 0.00% | -100.0% |
| Q3 2022 | $475,000 | +68.4% | 444,129 | +105.0% | 0.00% | – |
| Q2 2022 | $282,000 | +1.8% | 216,700 | +14.4% | 0.00% | – |
| Q1 2022 | $277,000 | -79.5% | 189,400 | +380.3% | 0.00% | -100.0% |
| Q1 2021 | $1,351,000 | +117.9% | 39,434 | +131.5% | 0.00% | +100.0% |
| Q4 2020 | $620,000 | +3.7% | 17,034 | +38.1% | 0.00% | 0.0% |
| Q3 2020 | $598,000 | – | 12,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 66,390 | $2,232,000 | 1.54% |
| BVF INC/IL | 591,811 | $19,897,000 | 0.75% |
| Endurant Capital Management LP | 53,369 | $1,794,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,183,213 | $39,780,000 | 0.30% |
| Perceptive Advisors | 1,370,000 | $46,060,000 | 0.30% |
| ACT CAPITAL MANAGEMENT, LLC | 16,071 | $541,000 | 0.28% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 516,956 | $17,380,000 | 0.26% |
| Parkman Healthcare Partners LLC | 31,402 | $1,056,000 | 0.23% |
| Insight Advisors, LLC/ PA | 19,150 | $582,000 | 0.18% |
| MYDA Advisors LLC | 20,000 | $672,000 | 0.17% |